Opendata, web and dolomites

NUTRI-NEED SIGNED

Final development, clinical validation and launch preparation of NL01, an innovative health ingredient for supplements, food products and foods for special medical purposes

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NUTRI-NEED project word cloud

Explore the words cloud of the NUTRI-NEED project. It provides you a very rough idea of what is the project "NUTRI-NEED" about.

resistance    immune    cumulative    obtain    medical    huge    humans    perform    isolation    115    clinically    works    proprietary    healthy    entry    company    data    small    approved    elderly    life    market    people    ingredient    nl01    first    safety    register    industrial    regulatory    advice    projected    consumers    clinical    population    friesland    dynamic    dsm    licensing    components    game    foods    46x    adults    preclinical    proven    food    nestl    changer    revenues    commercial    ingredients    risk    generate    registration    gt    shown    medium    demand    crop    efsa    desired    2026    supporting    plant    track    supports    kg    functional    purposes    complete    fresenius    infection    industry    isolated    leaders    claim    campina    infections    million    claims    live    benefits    young    status    health    ec    eacute    representing    licence    dietary    function    patients    inclusion    companies    nutrileads    grant    containing    supplements    launch    deals    danone    abbott    250   

Project "NUTRI-NEED" data sheet

The following table provides information about the project.

Coordinator
NUTRILEADS BV 

Organization address
address: BRONLAND 12 N
city: WAGENINGEN
postcode: 6708 WH
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Project website https://nutrileads.com/investors/
 Total cost 3˙567˙000 €
 EC max contribution 2˙496˙900 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NUTRILEADS BV NL (WAGENINGEN) coordinator 2˙496˙900.00

Map

 Project objective

People want to live a long and healthy life and there is a huge demand for food products to enable this. Among consumers, the most desired health benefits in food products and supplements are ‘supports immune function’ and ‘increases resistance to infections’.

NutriLeads is a dynamic Health Ingredients company developing crop-derived food ingredients with clinically proven health benefits. With its proprietary lead ingredient NL01, having completed preclinical data and proven safety in humans, NutriLeads is on track to become the first company to launch an ingredient with an approved health claim for supporting immune function and increasing infection resistance. Targeted end-users of NL01 containing food products (dietary supplements, medical- and functional foods) are young adults, adults, elderly and patients, aiming to support their health and immune status.

Nutrileads selected a common crop from which NL01 can be isolated, a game-changer for its commercial success,and developed the isolation process for NL01 up to small scale industrial plant production. In this project, Nutrileads will perform medium scale-up of the production process to 250 kg. Nutrileads will complete the data package for NL01 with a clinical study in a relevant population with increased infection risk to support the health claims on NL01, register NL01 as ‘Novel Food’ and obtain European Food Safety Authority (EFSA) regulatory advice on registration as ‘Food for Specific Medical Purposes’.

NutriLeads will generate revenues from out-licensing NL01 to large companies in the food industry. Market leaders Abbott, Nestlé, Friesland Campina, Danone, Fresenius regularly in-licence components for inclusion in their products; Nestlé and DSM have already shown interest in Nutrileads’ products. Nutrileads works towards market entry and first deals during or directly after this project with a projected best-case cumulative revenues of €115 million in 2026, representing >46x the EC grant.

 Deliverables

List of deliverables.
NL01 brand & logo Websites, patent fillings, videos etc. 2019-08-01 13:00:52

Take a look to the deliverables list in detail:  detailed list of NUTRI-NEED deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NUTRI-NEED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NUTRI-NEED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DetectInMen (2019)

Infection detection in human semen

Read More  

STURSKIN (2018)

Innovative products by using tanned sturgeon skin

Read More  

ADAPTOS (2019)

ADAPTOS - Changing the way bone voids are treated

Read More